NCT05144880

Brief Summary

Two groups of subjects will be included 55 subjects in electroacupuncture with 2Hz group, 55 subjects in the electroacupuncture with 100Hz group. The clinical efficacy of electroacupuncture with different frequencies (2 Hz, 100 Hz) in the treatment of MDD will be observed by evaluation indicators, such as Self-rating depression scale and Hamilton depression scale.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable major-depressive-disorder

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

January 31, 2023

Status Verified

January 1, 2023

Enrollment Period

2.2 years

First QC Date

November 14, 2021

Last Update Submit

January 27, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in anxiety and depression severity measure by Self-rating depression scale(SDS)

    This scale contains 20 items that reflect the subjective feelings of depression, 10 of which are positive scores and 10 are reverse scores. Each item is divided into four grades according to the frequency of symptoms, If it is a positive scoring question, it will be rated as 1, 2, 3, and 4 points; for a reverse scoring question, it will be rated as 4, 3, 2, and 1. After the evaluation, add up the scores in the 20 items to get the total rough score, and then multiply the rough score by 1.25 and take the integer part to get the standard score

    There will be evaluated before intervention, at 2, 4weeks after intervention and at the end of 4-weeks follow-up.

  • Change in the severity of depression measure by Hamilton depression scale (HAMD)

    This scale is performed by two trained raters to perform a HAMD, usually in the form of conversation and observation. After the examination, the two raters will score independently

    There will be evaluated before intervention, at 2, 4weeks after intervention and at the end of 4-weeks follow-up.

Secondary Outcomes (2)

  • Change in sleep quality measured by Insomnia severity index (ISI)

    There will be evaluated before intervention, at 2, 4weeks after intervention and at the end of 4-weeks follow-up.

  • Change in Traditional Chinese medicine syndrome score

    There will be evaluated before intervention, at 2, 4weeks after intervention and at the end of 4-weeks follow-up.

Study Arms (2)

electroacupuncture with 2Hz group

EXPERIMENTAL
Other: electroacupuncture

electroacupuncture with 100Hz group

EXPERIMENTAL
Other: electroacupuncture

Interventions

A total of 12 treatment sessions will be administered to each participant. The acupoints of needles inserted for each participant in each session are DU20, EX-HN1, DU29, HT17, PC6, RN6, RN4, LR3 and SP6. The needles will be manually stimulated by rotating, thrusting, stirring, etc. to produce ''De Qi'' sensation. Then we will use electroacupuncture for acupoint stimulation lasting 30min. The frequency will be set as 2Hz for the electroacupuncture with 2Hz group and the frequency will be set as 100Hz for the electroacupuncture with 100Hz group.

electroacupuncture with 100Hz groupelectroacupuncture with 2Hz group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients suffering from MDD in accordance with the diagnostic criteria;
  • Hamilton Depression Scale score is between 21 and 35 (mild to moderate MDD);
  • ≤age≤60 years, both gender;
  • Patients who have not used antidepressants and other psychiatric drugs (including traditional Chinese medicine), or have used them but have stopped for at least 2 weeks;
  • Patients have clear consciousness and could communicate with others normally;
  • Patients could understand the full study protocol and written informed consent is provided by themselves. Note: Subjects who meet the above six items will be included.

You may not qualify if:

  • Patients with bipolar disorder;
  • Patients with schizophrenia or other mental disorders;
  • Patients with severe medical diseases, tumors or diseases of the central nervous system;
  • Patients suffering from severe depressive episode with psychotic symptoms;
  • Suicidal patients;
  • Patients with seasonal depression;
  • Patients with organic depression;
  • Patients with alcohol or drug addicts;
  • Patients using other therapies;
  • Patients in pregnancy or lactation;
  • Patients suffering from cognitive dysfunction, aphasia or other diseases that cannot cooperate with treatment;
  • Patients with pacemakers;
  • Patients who are not suitable for electroacupuncture.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiaoyu Li

Hangzhou, Zhejiang, 310053, China

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Doctor

Study Record Dates

First Submitted

November 14, 2021

First Posted

December 3, 2021

Study Start

November 1, 2021

Primary Completion

December 30, 2023

Study Completion

December 30, 2024

Last Updated

January 31, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF, CSR

Locations